专题:Cutaneous Melanoma Detection and Management

This cluster of papers focuses on the diagnosis, treatment, and epidemiology of melanoma, a type of skin cancer. It covers topics such as dermatologist-level classification, genetic alterations, sentinel lymph node biopsy, immunotherapy, tumor staging, deep learning for melanoma recognition, and survival analysis. The papers also discuss the epidemiological trends and risk factors associated with melanoma.
最新文献
Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial

article Full Text OpenAlex

Efficacy of adjuvant anti‐ PD ‐1 antibody versus observation for resected nail apparatus melanoma

article Full Text OpenAlex

Privacy-Preserving Deep Learning for Disease Diagnosis in Medical Imaging: A Systematic Review

article Full Text OpenAlex

An Attention‐Guided Deep Learning Approach for Classifying 39 Skin Lesion Types

article Full Text OpenAlex

Predicting a metachronous cutaneous squamous cell carcinoma: a competing-risk model based on nationwide linked registries

preprint Full Text OpenAlex

Independent Dutch Validation Study of CP-GEP (Merlin Assay) for the Prediction of Nodal Metastasis and Long-Term Outcome in Patients with Primary Cutaneous Melanoma

article Full Text OpenAlex

Comprehensive Insights Into Basal Cell Carcinoma: Causes, Presentation, Prevention, and Modern Therapeutic Approaches

article Full Text OpenAlex

Lightweight Hybrid CNN Model with Explainable AI for Skin Lesion Classification

article Full Text OpenAlex

Long Term of Follow-Up of Melanoma-Associated Retinopathy: A Case Report

article Full Text OpenAlex

Caso de desensibilización exitosa con Temozolomida en paciente con reacción cutánea severa

article Full Text OpenAlex

近5年高被引文献
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma

article Full Text OpenAlex 1669 FWCI166.1676

Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040

article Full Text OpenAlex 1283 FWCI125.5674

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

article Full Text OpenAlex 758 FWCI178.6583

Cutaneous melanoma

review Full Text OpenAlex 591 FWCI137.8421

Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial

article Full Text OpenAlex 450 FWCI45.3206

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma

article Full Text OpenAlex 392 FWCI113.7301

Detection of Skin Cancer Based on Skin Lesion Images Using Deep Learning

article Full Text OpenAlex 331 FWCI32.6553

Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial

article Full Text OpenAlex 330 FWCI31.4965

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022

review Full Text OpenAlex 308 FWCI30.1362

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

article Full Text OpenAlex 290 FWCI43.3405